Global Pegfilgrastim Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Pegfilgrastim market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Pegfilgrastim market.
Major Players in the Pegfilgrastim market are:
Amgen Inc
Mylan (Biocon)
Dong-A Socio Group
Apotex
Coherus BioSciences (Coherus)
Dr. Reddys Laboratories
Sandoz (Novartis)
Cinfa Biotech
Stada Arzneimittel
On the basis of types, the Pegfilgrastim market is primarily split into:
Intravenous Injection
Subcutaneous Injection
On the basis of applications, the market covers:
Oncology
Hematological Disease
Other
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Pegfilgrastim Market Overview
- 1.1 Product Overview and Scope of Pegfilgrastim Market
- 1.2 Pegfilgrastim Market Segment by Type
- 1.2.1 Global Pegfilgrastim Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Pegfilgrastim Market Segment by Application
- 1.3.1 Pegfilgrastim Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Pegfilgrastim Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Pegfilgrastim (2017-2029)
- 1.5.1 Global Pegfilgrastim Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Pegfilgrastim Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Pegfilgrastim Industry
- 1.7 Impact of Carbon Neutrality on the Pegfilgrastim Industry
- 2 Pegfilgrastim Market Upstream and Downstream Analysis
- 2.1 Pegfilgrastim Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Pegfilgrastim Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 Amgen Inc
- 3.1.1 Amgen Inc Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Pegfilgrastim Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Mylan (Biocon)
- 3.2.1 Mylan (Biocon) Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Pegfilgrastim Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Dong-A Socio Group
- 3.3.1 Dong-A Socio Group Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Pegfilgrastim Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 Apotex
- 3.4.1 Apotex Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Pegfilgrastim Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 Coherus BioSciences (Coherus)
- 3.5.1 Coherus BioSciences (Coherus) Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Pegfilgrastim Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 Dr. Reddys Laboratories
- 3.6.1 Dr. Reddys Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Pegfilgrastim Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 Sandoz (Novartis)
- 3.7.1 Sandoz (Novartis) Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Pegfilgrastim Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 Cinfa Biotech
- 3.8.1 Cinfa Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Pegfilgrastim Market Performance (2017-2022)
- 3.8.4 Business Overview
- 3.9 Stada Arzneimittel
- 3.9.1 Stada Arzneimittel Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.9.2 Product Profiles, Application and Specification
- 3.9.3 Pegfilgrastim Market Performance (2017-2022)
- 3.9.4 Business Overview
- 4 Global Pegfilgrastim Market Landscape by Player
- 4.1 Global Pegfilgrastim Sales and Share by Player (2017-2022)
- 4.2 Global Pegfilgrastim Revenue and Market Share by Player (2017-2022)
- 4.3 Global Pegfilgrastim Average Price by Player (2017-2022)
- 4.4 Global Pegfilgrastim Gross Margin by Player (2017-2022)
- 4.5 Pegfilgrastim Market Competitive Situation and Trends
- 4.5.1 Pegfilgrastim Market Concentration Rate
- 4.5.2 Pegfilgrastim Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Pegfilgrastim Sales, Revenue, Price Trend by Type
- 5.1 Global Pegfilgrastim Sales and Market Share by Type (2017-2022)
- 5.2 Global Pegfilgrastim Revenue and Market Share by Type (2017-2022)
- 5.3 Global Pegfilgrastim Price by Type (2017-2022)
- 5.4 Global Pegfilgrastim Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Pegfilgrastim Sales, Revenue and Growth Rate of Intravenous Injection (2017-2022)
- 5.4.2 Global Pegfilgrastim Sales, Revenue and Growth Rate of Subcutaneous Injection (2017-2022)
- 6 Global Pegfilgrastim Market Analysis by Application
- 6.1 Global Pegfilgrastim Consumption and Market Share by Application (2017-2022)
- 6.2 Global Pegfilgrastim Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Pegfilgrastim Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Pegfilgrastim Consumption and Growth Rate of Oncology (2017-2022)
- 6.3.2 Global Pegfilgrastim Consumption and Growth Rate of Hematological Disease (2017-2022)
- 6.3.3 Global Pegfilgrastim Consumption and Growth Rate of Other (2017-2022)
- 7 Global Pegfilgrastim Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Pegfilgrastim Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Pegfilgrastim Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Pegfilgrastim Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Pegfilgrastim Market Forecast (2022-2029)
- 8.1 Global Pegfilgrastim Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Pegfilgrastim Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Pegfilgrastim Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Pegfilgrastim Price and Trend Forecast (2022-2029)
- 8.2 Global Pegfilgrastim Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Pegfilgrastim Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Pegfilgrastim Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Pegfilgrastim Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Pegfilgrastim Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Pegfilgrastim Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Pegfilgrastim Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Pegfilgrastim Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Pegfilgrastim Sales and Revenue Forecast (2022-2029)
- 8.3 Global Pegfilgrastim Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Pegfilgrastim Revenue and Growth Rate of Intravenous Injection (2022-2029)
- 8.3.2 Global Pegfilgrastim Revenue and Growth Rate of Subcutaneous Injection (2022-2029)
- 8.4 Global Pegfilgrastim Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Pegfilgrastim Consumption Value and Growth Rate of Oncology (2022-2029)
- 8.4.2 Global Pegfilgrastim Consumption Value and Growth Rate of Hematological Disease (2022-2029)
- 8.4.3 Global Pegfilgrastim Consumption Value and Growth Rate of Other (2022-2029)
- 8.5 Pegfilgrastim Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Pegfilgrastim Market Drivers Analysis
- 9.2 Pegfilgrastim Market Restraints and Challenges
- 9.3 Pegfilgrastim Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Pegfilgrastim Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Pegfilgrastim Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Pegfilgrastim Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook